Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis
Annalisa Ruggeri(Inserm), Vanderson Rocha(European Organisation for Rare Diseases), Marcos Augusto Mauad, Mohamad Mohty(Sorbonne Université), António Campos(Instituto Português de Oncologia Francisco Gentil), Franco Locatelli(Bambino Gesù Children's Hospital), Myriam Labopin(Sorbonne Université), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Duncan Purtill(Fiona Stanley Hospital), Maurizio Caniglia(Azienda Ospedaliera di Perugia), Marc Bierings(University Medical Center Utrecht), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Gérard Michel(Hôpital d'Enfants), J-H Dalle(Université Paris Cité), José María Pérez Hurtado(Hospital Universitario Virgen del Rocío), Renato Cunha(European Organisation for Rare Diseases), Nabil Kabbara(Université Paris Cité)
Cited by 50
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738